Recent analyses of clinical BC and PC samples [15,16] revealed the expression of IL-30 in cancer cells and in tumor- or draining-LN-infiltrating leukocytes, mostly CD68+ macrophages, CD33+CD11b+ myeloid cells, and CD14+ monocytes, whereas it was absent in the normal tissue counterparts. This evidence concerns the gene ITGAM and cancer.